Mouse Anti-MYOD1 Recombinant Antibody (1A7) (CBMAB-A5749-LY)
Basic Information
Formulations & Storage [For reference only, actual COA shall prevail!]
Target
Cellular response to glucocorticoid stimulus Source: Ensembl
Cellular response to oxygen levels Source: Ensembl
Cellular response to starvation Source: Ensembl
Cellular response to tumor necrosis factor Source: Ensembl
Histone H3 acetylation Source: UniProtKB
Histone H4 acetylation Source: UniProtKB
Muscle cell fate commitment Source: BHF-UCL
Muscle organ development Source: ProtInc
Myoblast fate determination Source: Ensembl
Myoblast fusion Source: Ensembl
Myotube cell development Source: BHF-UCL
Myotube differentiation involved in skeletal muscle regeneration Source: Ensembl
Negative regulation of chromatin binding Source: Ensembl
Negative regulation of myoblast proliferation Source: Ensembl
Positive regulation of binding Source: Ensembl
Positive regulation of muscle cell differentiation Source: BHF-UCL
Positive regulation of myoblast differentiation Source: GO_Central
Positive regulation of myoblast fusion Source: BHF-UCL
Positive regulation of skeletal muscle fiber development Source: GO_Central
Positive regulation of skeletal muscle tissue regeneration Source: Ensembl
Positive regulation of snRNA transcription by RNA polymerase II Source: UniProtKB
Positive regulation of transcription by RNA polymerase II Source: NTNU_SB
Protein phosphorylation Source: ProtInc
Regulation of alternative mRNA splicing, via spliceosome Source: Ensembl
Regulation of RNA splicing Source: BHF-UCL
Regulation of transcription by RNA polymerase II Source: GO_Central
Skeletal muscle cell differentiation Source: GO_Central
Skeletal muscle fiber adaptation Source: Ensembl
Skeletal muscle fiber development Source: Ensembl
Skeletal muscle tissue development Source: ProtInc
An autosomal recessive muscular disorder characterized by hypotonia and respiratory insufficiency apparent soon after birth, high diaphragmatic dome on imaging, poor overall growth, pectus excavatum, dysmorphic facies, and renal anomalies in some affected individuals. Additional variable features include delayed motor development, mildly decreased endurance, distal arthrogryposis, and lung hypoplasia resulting in early death.
Acetylated by a complex containing EP300 and PCAF. The acetylation is essential to activate target genes. Conversely, its deacetylation by SIRT1 inhibits its function (By similarity).
Ubiquitinated on the N-terminus; which is required for proteasomal degradation.
Methylation at Lys-104 by EHMT2/G9a inhibits myogenic activity.
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon
Submit a review
Loading...
Please try the standard protocols which include: protocols, troubleshooting and guide.
Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols
Related Products
Mouse Anti-MYOD1 Recombinant Antibody (CBFYM-3001) (CAT#: CBMAB-M3196-FY)
Mouse Anti-MYOD1 Recombinant Antibody (CBT4234) (CAT#: V2LY-0625-LY1951)
Mouse Anti-myod1 Antibody (D7F2) (CAT#: CBMAB-1442CQ)
Mouse Anti-MYOD1 Recombinant Antibody (A1277) (CAT#: CBMAB-AP12342LY)
Mouse Anti-MYOD1 Recombinant Antibody (CBFYM-3002) (CAT#: CBMAB-M3197-FY)
Mouse Anti-MYOD1 Recombinant Antibody (CF299) (CAT#: CBMAB-FT200LY)
Mouse Anti-MYOD1 Recombinant Antibody (A1278) (CAT#: CBMAB-AP4972LY)
Rabbit Anti-MYOD1 Recombinant Antibody (RM369) (CAT#: CBMAB-BR365LY)
Mouse Anti-MYOD1 Recombinant Antibody (A1276) (CAT#: CBMAB-AP4970LY)
Custom Antibody Labeling
We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).
Online InquiryContact us

